These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8895176)

  • 1. Criteria for the definition of the eosinophilia-myalgia syndrome.
    Hertzman PA
    J Rheumatol Suppl; 1996 Oct; 46():7-12. PubMed ID: 8895176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Centers for Disease Control and Prevention criteria for the eosinophilia-myalgia syndrome in a geographically defined population.
    Spitzer WO; Haggerty JL; Berkson L; Davis W; Palmer W; Tamblyn R; Laprise R; Mulder LJ
    J Rheumatol Suppl; 1996 Oct; 46():73-9; discussion 79-80. PubMed ID: 8895183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The eosinophilia-myalgia syndrome: what we know, what we think we know, and what we need to know.
    Clauw DJ; Pincus T
    J Rheumatol Suppl; 1996 Oct; 46():2-6. PubMed ID: 8895175
    [No Abstract]   [Full Text] [Related]  

  • 4. Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic cases.
    Sullivan EA; Staehling N; Philen RM
    J Rheumatol; 1996 Oct; 23(10):1784-7. PubMed ID: 8895159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A diagnostic algorithm for distinguishing the eosinophilia-myalgia syndrome from fibromyalgia and chronic myofascial pain.
    Taylor RM; Gabriel SE; O'Fallon WM; Bowles CA; Duffy J
    J Rheumatol Suppl; 1996 Oct; 46():13-8. PubMed ID: 8895177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibromyalgia, psychiatric disorders, and assessment of the longterm outcome of eosinophilia-myalgia syndrome.
    Hudson JI; Pope HG; Carter WP; Daniels SR
    J Rheumatol Suppl; 1996 Oct; 46():37-42; discussion 42-3. PubMed ID: 8895180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilia-myalgia syndrome: patient status 2-4 years after onset.
    Pincus T
    J Rheumatol Suppl; 1996 Oct; 46():19-24; discussion 24-5. PubMed ID: 8895178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic bias in clinical decision making: an example of L-tryptophan and the diagnosis of eosinophilia-myalgia syndrome.
    Wagner KR; Elmore JG; Horwitz RI
    J Rheumatol; 1996 Dec; 23(12):2079-85. PubMed ID: 8970044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing symptomatic HIV infection and AIDS in adults.
    AIDS Action; 1993; (20):6-8. PubMed ID: 12288934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic rheumatic disorders.
    Clauw DJ; Crofford LJ
    Rheum Dis Clin North Am; 1995 Feb; 21(1):231-46. PubMed ID: 7732171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilia-myalgia syndrome: mortality data from the US national surveillance system.
    Swygert LA; Back EE; Auerbach SB; Sewell LE; Falk H
    J Rheumatol; 1993 Oct; 20(10):1711-7. PubMed ID: 8295183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome.
    Horwitz RI; Daniels SR
    J Rheumatol Suppl; 1996 Oct; 46():60-72. PubMed ID: 8895182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique.
    Shapiro S
    J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head and neck manifestations of eosinophilia-myalgia syndrome.
    Levine B; Lanza DC; Ficco A; Freundlich B
    Ann Otol Rhinol Laryngol; 1995 Feb; 104(2):90-9. PubMed ID: 7857025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
    Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
    Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of the eosinophilia-myalgia syndrome.
    Silver RM
    J Rheumatol Suppl; 1996 Oct; 46():26-36. PubMed ID: 8895179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic fasciitis: report of a case diagnosed 14 years after its onset.
    Ferlazzo B; Quattrocchi P; Carretti C; La Rosa G; Barresi G
    Minerva Med; 1995 Nov; 86(11):495-8. PubMed ID: 8684673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of eosinophilia-myalgia syndrome complicated with recurrent parotitis].
    Akiyama Y; Suzuki T; Tanaka M; Imai F; Asaoka T; Sakamoto Y; Kitamura K
    Arerugi; 1997 Dec; 46(12):1273-6. PubMed ID: 9503688
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurologic, MR imaging, and MR spectroscopic findings in eosinophilia myalgia syndrome.
    Haseler LJ; Sibbitt WL; Sibbitt RR; Hart BL
    AJNR Am J Neuroradiol; 1998 Oct; 19(9):1687-94. PubMed ID: 9802492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome.
    Kilbourne EM; Philen RM; Kamb ML; Falk H
    J Rheumatol Suppl; 1996 Oct; 46():81-8; discussion 89-91. PubMed ID: 8895184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.